Regeneron Jacks Up Research Budget 32%

Tuesday, August 4, 2015

Source: FierceBiotech

Regeneron ($REGN), toasting the approval of its latest treatment and riding the success of its last one, is investing more and more into R&D, lining up a stable of new therapies with blockbuster ambitions.

View All News »